Women in Psychedelics Announces Atai as Platinum Sponsor

TORONTO–()–The Women in Psychedelics Network (“WIPN” Where “Network”), a network of professionals from all corners of the psychedelic industry strengthening women’s voices and providing opportunities to advance mental health solutions, atai Life Sciences NV (NASDAQ: ATAI) announced today (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, as a platinum sponsor of the Network, through its philanthropic arm atai Impact.

WIPN and atai are mutually aligned in their efforts to support women’s leadership by changing the way we treat mental health and positively impacting the development of the psychedelic field. In a recent McKinsey report, less than 25% of white women hold leadership positions in the workplace, and less than 10% of women of color do so. The psychedelic sector is no different. WIPN responds to the need by promoting female-led educational events, career development, partnership and funding, and mentorship.

“atai Impact is proud to sponsor WIPN to recognize and celebrate the role women have played in the psychedelic space for decades, as well as to create new opportunities for engagement and recognition. We look forward to using the resources of this group and we are developing our own internal diversity, equity and inclusion initiatives,” said Rae Richman, Head of atai Impact. “atai is very much aligned with WIPN’s passion to champion the advancement of women in this field and I am honored to serve on the board of this organization,” said Sarah Popham, vice president of regulatory affairs at atai and WIPN board member.

“We believe WIPN will play a vital role in the psychedelic industry and hope to help further support inclusiveness and diversity industry-wide,” added Najla Guthrie, President of WIPN. “We are working hard to expand opportunities for more women to participate in this field and having the support of important sponsors like atai and our many other great sponsors across all disciplines is fundamental to our efforts to maximize women’s access in this space.”

About the Women in Psychedelics Network

The Women in Psychedelics Network is a collective of brilliant psychedelic industry professionals promoting inclusion and innovation and strengthening women’s voices in the space. The WIPN Network spans across North America and meets virtually and in person for education, workshops, mentorship and networking opportunities for women in the psychedelic industry. Register for the inaugural Miami event on November 4, 2022 here. For more information, please visit www.womeninpsychedelicsnetwork.com.

About atai Impact

atai Impact was launched by atai Life Sciences, in October 2021, to harness the power of innovative mental health approaches for positive social change.

The main pillars of atai Impact’s activities are: advancing education, expanding access, and supporting the broader mental health care ecosystem. atai Impact initially focuses on the psychedelic sector, given its emerging potential in addressing the growing mental health crisis.

The creation of atai Impact is based on the position of atai Life Sciences that harmonization between commercial and non-profit entities represents the best way forward to address all aspects of the escalating global mental crisis. .

About atai Life Sciences

atai Life Sciences is a clinical-stage biopharmaceutical company focused on transforming the treatment of mental health disorders. Founded in 2018 in response to the significant unmet need and lack of innovation in the mental health treatment landscape, atai is dedicated to the acquisition, incubation and effective development of innovative therapies to treat mental illness. depression, anxiety, substance abuse and other mental health disorders.

By pooling resources and best practices, atai aims to responsibly accelerate the development of new medicines across its companies to achieve clinically meaningful and lasting behavior change in mental health patients.

atai’s vision is to heal mental health disorders so that everyone, everywhere can live a more fulfilled life. For more information, please visit www.atai.life.

Notice regarding forward-looking information:

This press release contains forward-looking statements, including, but not limited to, statements regarding the network’s business, assets, or investments, and other statements that are not historical facts. Readers are cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are based will occur. By their nature, forward-looking statements involve numerous known and unknown assumptions, risks and uncertainties, both general and specific, which contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will not be achieved, which may cause performance and results in future periods to differ materially from any estimate or projection of future performance or results expressed or implied by such forward-looking statements. These assumptions, risks and uncertainties include, among other things, the state of the economy in general and of the financial markets in particular, the interest of investors in the activities and the prospects of the Network.

The forward-looking statements contained in this press release are made as of the date of this press release. Except as required by law, the Network disclaims any intention and undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, unless the applicable securities law requires it. Further, the Network assumes no obligation to comment on expectations or statements made by third parties with respect to the matters discussed above.

#Women #Psychedelics #Announces #Atai #Platinum #Sponsor

Related Articles

Back to top button